Research

Energy balance

Activation of AMP-activated protein kinase (AMPK) reverses metabolic defects associated with insulin resistance and improves glucose tolerance in type 2 diabetes.

For individuals with insulin resistance or type 2 diabetes, activating AMPK through medications like metformin can significantly improve metabolic health by enhancing insulin sensitivity and glucose tolerance. This works by shifting cellular metabolism towards energy-efficient oxidative pathways and reducing lipid accumulation in tissues like the liver and muscle.

GoodSupportsHIGH confidence
AMPK-activating drugs reverse many of the metabolic defects associated with insulin resistance, and recent studies suggest that the insulin-sensitizing effects of the widely used anti-diabetic drug, metformin, are mediated by AMPK.
D. Grahame Hardie · Journal of Internal Medicine · 2014

Why this rating

The paper is a comprehensive review citing numerous animal models, human genetic studies, and clinical drug data (metformin).

Source

<scp>AMP</scp>‐activated protein kinase: a key regulator of energy balance with many roles in human disease

D. Grahame Hardie · Journal of Internal Medicine · 2014

DOI 10.1111/joim.12268

narrative_reviewCited 273×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →